nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—coronary artery disease	0.174	1	CbGaD
Lenalidomide—PTGS2—Acetylsalicylic acid—coronary artery disease	0.0533	0.133	CbGbCtD
Lenalidomide—ABCB1—Ticagrelor—coronary artery disease	0.0453	0.113	CbGbCtD
Lenalidomide—ABCB1—Perindopril—coronary artery disease	0.028	0.0698	CbGbCtD
Lenalidomide—ABCB1—Clopidogrel—coronary artery disease	0.028	0.0698	CbGbCtD
Lenalidomide—ABCB1—Telmisartan—coronary artery disease	0.0245	0.061	CbGbCtD
Lenalidomide—ABCB1—Pitavastatin—coronary artery disease	0.0245	0.061	CbGbCtD
Lenalidomide—ABCB1—Lisinopril—coronary artery disease	0.0232	0.0579	CbGbCtD
Lenalidomide—ABCB1—Enalapril—coronary artery disease	0.0232	0.0579	CbGbCtD
Lenalidomide—ABCB1—Timolol—coronary artery disease	0.0197	0.0492	CbGbCtD
Lenalidomide—ABCB1—Ezetimibe—coronary artery disease	0.0181	0.045	CbGbCtD
Lenalidomide—ABCB1—Acetylsalicylic acid—coronary artery disease	0.0176	0.0439	CbGbCtD
Lenalidomide—ABCB1—Captopril—coronary artery disease	0.0174	0.0433	CbGbCtD
Lenalidomide—ABCB1—Simvastatin—coronary artery disease	0.0168	0.0418	CbGbCtD
Lenalidomide—ABCB1—Pravastatin—coronary artery disease	0.0164	0.0409	CbGbCtD
Lenalidomide—ABCB1—Lovastatin—coronary artery disease	0.0164	0.0409	CbGbCtD
Lenalidomide—ABCB1—Atorvastatin—coronary artery disease	0.015	0.0373	CbGbCtD
Lenalidomide—ABCB1—Losartan—coronary artery disease	0.0137	0.0341	CbGbCtD
Lenalidomide—CDH5—artery—coronary artery disease	0.00794	0.154	CbGeAlD
Lenalidomide—CDH5—endothelium—coronary artery disease	0.00671	0.13	CbGeAlD
Lenalidomide—CDH5—cardiac ventricle—coronary artery disease	0.00445	0.0863	CbGeAlD
Lenalidomide—CDH5—myocardium—coronary artery disease	0.00419	0.0812	CbGeAlD
Lenalidomide—CDH5—heart—coronary artery disease	0.00292	0.0566	CbGeAlD
Lenalidomide—TNFSF11—blood—coronary artery disease	0.0029	0.0562	CbGeAlD
Lenalidomide—CRBN—cardiac ventricle—coronary artery disease	0.00283	0.0548	CbGeAlD
Lenalidomide—CDH5—cardiovascular system—coronary artery disease	0.00276	0.0535	CbGeAlD
Lenalidomide—CRBN—myocardium—coronary artery disease	0.00266	0.0516	CbGeAlD
Lenalidomide—CDH5—cardiac atrium—coronary artery disease	0.0025	0.0484	CbGeAlD
Lenalidomide—CDH5—blood—coronary artery disease	0.00218	0.0423	CbGeAlD
Lenalidomide—CRBN—heart—coronary artery disease	0.00186	0.036	CbGeAlD
Lenalidomide—CRBN—cardiac atrium—coronary artery disease	0.00159	0.0308	CbGeAlD
Lenalidomide—CRBN—blood—coronary artery disease	0.00139	0.0269	CbGeAlD
Lenalidomide—PTGS2—artery—coronary artery disease	0.00137	0.0266	CbGeAlD
Lenalidomide—Pomalidomide—TNF—coronary artery disease	0.00125	0.343	CrCbGaD
Lenalidomide—PTGS2—endothelium—coronary artery disease	0.00116	0.0225	CbGeAlD
Lenalidomide—Thalidomide—TNF—coronary artery disease	0.000807	0.221	CrCbGaD
Lenalidomide—Thalidomide—CYP2C19—coronary artery disease	0.000615	0.169	CrCbGaD
Lenalidomide—Pomalidomide—PTGS2—coronary artery disease	0.000595	0.163	CrCbGaD
Lenalidomide—PTGS2—heart—coronary artery disease	0.000506	0.0098	CbGeAlD
Lenalidomide—PTGS2—cardiovascular system—coronary artery disease	0.000477	0.00925	CbGeAlD
Lenalidomide—Thalidomide—PTGS2—coronary artery disease	0.000383	0.105	CrCbGaD
Lenalidomide—PTGS2—blood—coronary artery disease	0.000377	0.00731	CbGeAlD
Lenalidomide—ABCB1—heart—coronary artery disease	0.000313	0.00606	CbGeAlD
Lenalidomide—ABCB1—cardiovascular system—coronary artery disease	0.000295	0.00572	CbGeAlD
Lenalidomide—ABCB1—blood—coronary artery disease	0.000233	0.00452	CbGeAlD
Lenalidomide—Asthenia—Niacin—coronary artery disease	3.75e-05	0.000146	CcSEcCtD
Lenalidomide—Fatigue—Losartan—coronary artery disease	3.74e-05	0.000146	CcSEcCtD
Lenalidomide—Headache—Ezetimibe—coronary artery disease	3.73e-05	0.000146	CcSEcCtD
Lenalidomide—Malaise—Lisinopril—coronary artery disease	3.73e-05	0.000146	CcSEcCtD
Lenalidomide—Oedema—Ramipril—coronary artery disease	3.72e-05	0.000146	CcSEcCtD
Lenalidomide—Vertigo—Lisinopril—coronary artery disease	3.72e-05	0.000145	CcSEcCtD
Lenalidomide—Dry mouth—Timolol—coronary artery disease	3.71e-05	0.000145	CcSEcCtD
Lenalidomide—Pain—Losartan—coronary artery disease	3.71e-05	0.000145	CcSEcCtD
Lenalidomide—Constipation—Losartan—coronary artery disease	3.71e-05	0.000145	CcSEcCtD
Lenalidomide—Syncope—Lisinopril—coronary artery disease	3.71e-05	0.000145	CcSEcCtD
Lenalidomide—Vomiting—Eplerenone—coronary artery disease	3.71e-05	0.000145	CcSEcCtD
Lenalidomide—Feeling abnormal—Furosemide—coronary artery disease	3.71e-05	0.000145	CcSEcCtD
Lenalidomide—Leukopenia—Lisinopril—coronary artery disease	3.7e-05	0.000145	CcSEcCtD
Lenalidomide—Nausea—Fenofibrate—coronary artery disease	3.7e-05	0.000145	CcSEcCtD
Lenalidomide—Pruritus—Niacin—coronary artery disease	3.69e-05	0.000144	CcSEcCtD
Lenalidomide—Asthenia—Pravastatin—coronary artery disease	3.69e-05	0.000144	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Furosemide—coronary artery disease	3.68e-05	0.000144	CcSEcCtD
Lenalidomide—Rash—Eplerenone—coronary artery disease	3.68e-05	0.000144	CcSEcCtD
Lenalidomide—Urticaria—Perindopril—coronary artery disease	3.68e-05	0.000144	CcSEcCtD
Lenalidomide—Hypersensitivity—Trandolapril—coronary artery disease	3.68e-05	0.000144	CcSEcCtD
Lenalidomide—Dermatitis—Eplerenone—coronary artery disease	3.68e-05	0.000144	CcSEcCtD
Lenalidomide—Diarrhoea—Valsartan—coronary artery disease	3.67e-05	0.000144	CcSEcCtD
Lenalidomide—Confusional state—Timolol—coronary artery disease	3.67e-05	0.000144	CcSEcCtD
Lenalidomide—Shock—Ramipril—coronary artery disease	3.66e-05	0.000143	CcSEcCtD
Lenalidomide—Hypersensitivity—Enalapril—coronary artery disease	3.66e-05	0.000143	CcSEcCtD
Lenalidomide—Abdominal pain—Perindopril—coronary artery disease	3.66e-05	0.000143	CcSEcCtD
Lenalidomide—Body temperature increased—Perindopril—coronary artery disease	3.66e-05	0.000143	CcSEcCtD
Lenalidomide—Palpitations—Lisinopril—coronary artery disease	3.66e-05	0.000143	CcSEcCtD
Lenalidomide—Diarrhoea—Olmesartan—coronary artery disease	3.66e-05	0.000143	CcSEcCtD
Lenalidomide—Headache—Eplerenone—coronary artery disease	3.66e-05	0.000143	CcSEcCtD
Lenalidomide—Nervous system disorder—Ramipril—coronary artery disease	3.65e-05	0.000143	CcSEcCtD
Lenalidomide—Thrombocytopenia—Ramipril—coronary artery disease	3.65e-05	0.000143	CcSEcCtD
Lenalidomide—Oedema—Timolol—coronary artery disease	3.64e-05	0.000142	CcSEcCtD
Lenalidomide—Pruritus—Pravastatin—coronary artery disease	3.64e-05	0.000142	CcSEcCtD
Lenalidomide—Loss of consciousness—Lisinopril—coronary artery disease	3.64e-05	0.000142	CcSEcCtD
Lenalidomide—Nausea—Clopidogrel—coronary artery disease	3.63e-05	0.000142	CcSEcCtD
Lenalidomide—Tachycardia—Ramipril—coronary artery disease	3.63e-05	0.000142	CcSEcCtD
Lenalidomide—Skin disorder—Ramipril—coronary artery disease	3.62e-05	0.000141	CcSEcCtD
Lenalidomide—Infection—Timolol—coronary artery disease	3.62e-05	0.000141	CcSEcCtD
Lenalidomide—Vomiting—Simvastatin—coronary artery disease	3.61e-05	0.000141	CcSEcCtD
Lenalidomide—Hypersensitivity—Telmisartan—coronary artery disease	3.61e-05	0.000141	CcSEcCtD
Lenalidomide—Cough—Lisinopril—coronary artery disease	3.61e-05	0.000141	CcSEcCtD
Lenalidomide—Nausea—Lovastatin—coronary artery disease	3.61e-05	0.000141	CcSEcCtD
Lenalidomide—Hyperhidrosis—Ramipril—coronary artery disease	3.6e-05	0.000141	CcSEcCtD
Lenalidomide—Rash—Simvastatin—coronary artery disease	3.58e-05	0.00014	CcSEcCtD
Lenalidomide—Dermatitis—Simvastatin—coronary artery disease	3.58e-05	0.00014	CcSEcCtD
Lenalidomide—Asthenia—Trandolapril—coronary artery disease	3.58e-05	0.00014	CcSEcCtD
Lenalidomide—Shock—Timolol—coronary artery disease	3.58e-05	0.00014	CcSEcCtD
Lenalidomide—Feeling abnormal—Losartan—coronary artery disease	3.58e-05	0.00014	CcSEcCtD
Lenalidomide—Urticaria—Furosemide—coronary artery disease	3.57e-05	0.00014	CcSEcCtD
Lenalidomide—Diarrhoea—Niacin—coronary artery disease	3.57e-05	0.00014	CcSEcCtD
Lenalidomide—Nervous system disorder—Timolol—coronary artery disease	3.57e-05	0.00014	CcSEcCtD
Lenalidomide—Asthenia—Enalapril—coronary artery disease	3.57e-05	0.000139	CcSEcCtD
Lenalidomide—Headache—Simvastatin—coronary artery disease	3.56e-05	0.000139	CcSEcCtD
Lenalidomide—Body temperature increased—Furosemide—coronary artery disease	3.56e-05	0.000139	CcSEcCtD
Lenalidomide—Abdominal pain—Furosemide—coronary artery disease	3.56e-05	0.000139	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Losartan—coronary artery disease	3.55e-05	0.000139	CcSEcCtD
Lenalidomide—Dizziness—Valsartan—coronary artery disease	3.55e-05	0.000139	CcSEcCtD
Lenalidomide—Anorexia—Ramipril—coronary artery disease	3.55e-05	0.000139	CcSEcCtD
Lenalidomide—Nausea—Ezetimibe—coronary artery disease	3.54e-05	0.000138	CcSEcCtD
Lenalidomide—Skin disorder—Timolol—coronary artery disease	3.54e-05	0.000138	CcSEcCtD
Lenalidomide—Dizziness—Olmesartan—coronary artery disease	3.53e-05	0.000138	CcSEcCtD
Lenalidomide—Pruritus—Trandolapril—coronary artery disease	3.53e-05	0.000138	CcSEcCtD
Lenalidomide—Chest pain—Lisinopril—coronary artery disease	3.52e-05	0.000138	CcSEcCtD
Lenalidomide—Arthralgia—Lisinopril—coronary artery disease	3.52e-05	0.000138	CcSEcCtD
Lenalidomide—Myalgia—Lisinopril—coronary artery disease	3.52e-05	0.000138	CcSEcCtD
Lenalidomide—Hyperhidrosis—Timolol—coronary artery disease	3.52e-05	0.000138	CcSEcCtD
Lenalidomide—Asthenia—Telmisartan—coronary artery disease	3.52e-05	0.000138	CcSEcCtD
Lenalidomide—Pruritus—Enalapril—coronary artery disease	3.52e-05	0.000138	CcSEcCtD
Lenalidomide—Diarrhoea—Pravastatin—coronary artery disease	3.52e-05	0.000138	CcSEcCtD
Lenalidomide—Anxiety—Lisinopril—coronary artery disease	3.51e-05	0.000137	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.5e-05	0.000137	CcSEcCtD
Lenalidomide—Discomfort—Lisinopril—coronary artery disease	3.48e-05	0.000136	CcSEcCtD
Lenalidomide—Hypotension—Ramipril—coronary artery disease	3.48e-05	0.000136	CcSEcCtD
Lenalidomide—Anorexia—Timolol—coronary artery disease	3.47e-05	0.000136	CcSEcCtD
Lenalidomide—Pruritus—Telmisartan—coronary artery disease	3.47e-05	0.000136	CcSEcCtD
Lenalidomide—Nausea—Eplerenone—coronary artery disease	3.47e-05	0.000136	CcSEcCtD
Lenalidomide—Dizziness—Niacin—coronary artery disease	3.45e-05	0.000135	CcSEcCtD
Lenalidomide—Urticaria—Losartan—coronary artery disease	3.45e-05	0.000135	CcSEcCtD
Lenalidomide—Dry mouth—Lisinopril—coronary artery disease	3.44e-05	0.000135	CcSEcCtD
Lenalidomide—Body temperature increased—Losartan—coronary artery disease	3.43e-05	0.000134	CcSEcCtD
Lenalidomide—Abdominal pain—Losartan—coronary artery disease	3.43e-05	0.000134	CcSEcCtD
Lenalidomide—Asthenia—Captopril—coronary artery disease	3.42e-05	0.000134	CcSEcCtD
Lenalidomide—Diarrhoea—Trandolapril—coronary artery disease	3.41e-05	0.000134	CcSEcCtD
Lenalidomide—Vomiting—Valsartan—coronary artery disease	3.41e-05	0.000133	CcSEcCtD
Lenalidomide—Confusional state—Lisinopril—coronary artery disease	3.4e-05	0.000133	CcSEcCtD
Lenalidomide—Diarrhoea—Enalapril—coronary artery disease	3.4e-05	0.000133	CcSEcCtD
Lenalidomide—Hypotension—Timolol—coronary artery disease	3.4e-05	0.000133	CcSEcCtD
Lenalidomide—Dizziness—Pravastatin—coronary artery disease	3.4e-05	0.000133	CcSEcCtD
Lenalidomide—Vomiting—Olmesartan—coronary artery disease	3.4e-05	0.000133	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.39e-05	0.000133	CcSEcCtD
Lenalidomide—Rash—Valsartan—coronary artery disease	3.38e-05	0.000132	CcSEcCtD
Lenalidomide—Dermatitis—Valsartan—coronary artery disease	3.38e-05	0.000132	CcSEcCtD
Lenalidomide—Nausea—Simvastatin—coronary artery disease	3.38e-05	0.000132	CcSEcCtD
Lenalidomide—Oedema—Lisinopril—coronary artery disease	3.38e-05	0.000132	CcSEcCtD
Lenalidomide—Pruritus—Captopril—coronary artery disease	3.37e-05	0.000132	CcSEcCtD
Lenalidomide—Rash—Olmesartan—coronary artery disease	3.37e-05	0.000132	CcSEcCtD
Lenalidomide—Insomnia—Ramipril—coronary artery disease	3.37e-05	0.000132	CcSEcCtD
Lenalidomide—Dermatitis—Olmesartan—coronary artery disease	3.37e-05	0.000132	CcSEcCtD
Lenalidomide—Headache—Valsartan—coronary artery disease	3.36e-05	0.000132	CcSEcCtD
Lenalidomide—Diarrhoea—Telmisartan—coronary artery disease	3.35e-05	0.000131	CcSEcCtD
Lenalidomide—Infection—Lisinopril—coronary artery disease	3.35e-05	0.000131	CcSEcCtD
Lenalidomide—Headache—Olmesartan—coronary artery disease	3.35e-05	0.000131	CcSEcCtD
Lenalidomide—Paraesthesia—Ramipril—coronary artery disease	3.34e-05	0.000131	CcSEcCtD
Lenalidomide—Shock—Lisinopril—coronary artery disease	3.32e-05	0.00013	CcSEcCtD
Lenalidomide—Asthenia—Perindopril—coronary artery disease	3.32e-05	0.00013	CcSEcCtD
Lenalidomide—Dyspnoea—Ramipril—coronary artery disease	3.32e-05	0.00013	CcSEcCtD
Lenalidomide—Vomiting—Niacin—coronary artery disease	3.32e-05	0.00013	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Timolol—coronary artery disease	3.32e-05	0.00013	CcSEcCtD
Lenalidomide—Hypersensitivity—Furosemide—coronary artery disease	3.32e-05	0.00013	CcSEcCtD
Lenalidomide—Somnolence—Ramipril—coronary artery disease	3.31e-05	0.000129	CcSEcCtD
Lenalidomide—Thrombocytopenia—Lisinopril—coronary artery disease	3.31e-05	0.000129	CcSEcCtD
Lenalidomide—Dizziness—Trandolapril—coronary artery disease	3.3e-05	0.000129	CcSEcCtD
Lenalidomide—Tachycardia—Lisinopril—coronary artery disease	3.3e-05	0.000129	CcSEcCtD
Lenalidomide—Insomnia—Timolol—coronary artery disease	3.29e-05	0.000129	CcSEcCtD
Lenalidomide—Rash—Niacin—coronary artery disease	3.29e-05	0.000129	CcSEcCtD
Lenalidomide—Dermatitis—Niacin—coronary artery disease	3.29e-05	0.000129	CcSEcCtD
Lenalidomide—Dizziness—Enalapril—coronary artery disease	3.29e-05	0.000129	CcSEcCtD
Lenalidomide—Skin disorder—Lisinopril—coronary artery disease	3.28e-05	0.000128	CcSEcCtD
Lenalidomide—Dyspepsia—Ramipril—coronary artery disease	3.28e-05	0.000128	CcSEcCtD
Lenalidomide—Pruritus—Perindopril—coronary artery disease	3.27e-05	0.000128	CcSEcCtD
Lenalidomide—Headache—Niacin—coronary artery disease	3.27e-05	0.000128	CcSEcCtD
Lenalidomide—Paraesthesia—Timolol—coronary artery disease	3.27e-05	0.000128	CcSEcCtD
Lenalidomide—Vomiting—Pravastatin—coronary artery disease	3.27e-05	0.000128	CcSEcCtD
Lenalidomide—Hyperhidrosis—Lisinopril—coronary artery disease	3.26e-05	0.000128	CcSEcCtD
Lenalidomide—Diarrhoea—Captopril—coronary artery disease	3.26e-05	0.000128	CcSEcCtD
Lenalidomide—Dyspnoea—Timolol—coronary artery disease	3.24e-05	0.000127	CcSEcCtD
Lenalidomide—Dizziness—Telmisartan—coronary artery disease	3.24e-05	0.000127	CcSEcCtD
Lenalidomide—Rash—Pravastatin—coronary artery disease	3.24e-05	0.000127	CcSEcCtD
Lenalidomide—Dermatitis—Pravastatin—coronary artery disease	3.24e-05	0.000127	CcSEcCtD
Lenalidomide—Decreased appetite—Ramipril—coronary artery disease	3.24e-05	0.000127	CcSEcCtD
Lenalidomide—Somnolence—Timolol—coronary artery disease	3.24e-05	0.000127	CcSEcCtD
Lenalidomide—Asthenia—Furosemide—coronary artery disease	3.23e-05	0.000126	CcSEcCtD
Lenalidomide—Headache—Pravastatin—coronary artery disease	3.22e-05	0.000126	CcSEcCtD
Lenalidomide—Anorexia—Lisinopril—coronary artery disease	3.22e-05	0.000126	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Ramipril—coronary artery disease	3.21e-05	0.000126	CcSEcCtD
Lenalidomide—Fatigue—Ramipril—coronary artery disease	3.21e-05	0.000126	CcSEcCtD
Lenalidomide—Dyspepsia—Timolol—coronary artery disease	3.2e-05	0.000125	CcSEcCtD
Lenalidomide—Hypersensitivity—Losartan—coronary artery disease	3.2e-05	0.000125	CcSEcCtD
Lenalidomide—Nausea—Valsartan—coronary artery disease	3.19e-05	0.000125	CcSEcCtD
Lenalidomide—Pruritus—Furosemide—coronary artery disease	3.18e-05	0.000124	CcSEcCtD
Lenalidomide—Constipation—Ramipril—coronary artery disease	3.18e-05	0.000124	CcSEcCtD
Lenalidomide—Nausea—Olmesartan—coronary artery disease	3.17e-05	0.000124	CcSEcCtD
Lenalidomide—Vomiting—Trandolapril—coronary artery disease	3.17e-05	0.000124	CcSEcCtD
Lenalidomide—Diarrhoea—Perindopril—coronary artery disease	3.17e-05	0.000124	CcSEcCtD
Lenalidomide—Decreased appetite—Timolol—coronary artery disease	3.16e-05	0.000124	CcSEcCtD
Lenalidomide—Vomiting—Enalapril—coronary artery disease	3.16e-05	0.000124	CcSEcCtD
Lenalidomide—Hypotension—Lisinopril—coronary artery disease	3.15e-05	0.000123	CcSEcCtD
Lenalidomide—Dizziness—Captopril—coronary artery disease	3.15e-05	0.000123	CcSEcCtD
Lenalidomide—Rash—Trandolapril—coronary artery disease	3.15e-05	0.000123	CcSEcCtD
Lenalidomide—Dermatitis—Trandolapril—coronary artery disease	3.14e-05	0.000123	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Timolol—coronary artery disease	3.14e-05	0.000123	CcSEcCtD
Lenalidomide—Fatigue—Timolol—coronary artery disease	3.14e-05	0.000123	CcSEcCtD
Lenalidomide—Rash—Enalapril—coronary artery disease	3.13e-05	0.000123	CcSEcCtD
Lenalidomide—Dermatitis—Enalapril—coronary artery disease	3.13e-05	0.000122	CcSEcCtD
Lenalidomide—Headache—Trandolapril—coronary artery disease	3.13e-05	0.000122	CcSEcCtD
Lenalidomide—Vomiting—Telmisartan—coronary artery disease	3.12e-05	0.000122	CcSEcCtD
Lenalidomide—Asthenia—Losartan—coronary artery disease	3.12e-05	0.000122	CcSEcCtD
Lenalidomide—Headache—Enalapril—coronary artery disease	3.11e-05	0.000122	CcSEcCtD
Lenalidomide—Pain—Timolol—coronary artery disease	3.11e-05	0.000122	CcSEcCtD
Lenalidomide—Nausea—Niacin—coronary artery disease	3.1e-05	0.000121	CcSEcCtD
Lenalidomide—Rash—Telmisartan—coronary artery disease	3.09e-05	0.000121	CcSEcCtD
Lenalidomide—Dermatitis—Telmisartan—coronary artery disease	3.09e-05	0.000121	CcSEcCtD
Lenalidomide—Diarrhoea—Furosemide—coronary artery disease	3.08e-05	0.00012	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.08e-05	0.00012	CcSEcCtD
Lenalidomide—Pruritus—Losartan—coronary artery disease	3.07e-05	0.00012	CcSEcCtD
Lenalidomide—Headache—Telmisartan—coronary artery disease	3.07e-05	0.00012	CcSEcCtD
Lenalidomide—Feeling abnormal—Ramipril—coronary artery disease	3.07e-05	0.00012	CcSEcCtD
Lenalidomide—Dizziness—Perindopril—coronary artery disease	3.06e-05	0.00012	CcSEcCtD
Lenalidomide—Insomnia—Lisinopril—coronary artery disease	3.05e-05	0.000119	CcSEcCtD
Lenalidomide—Nausea—Pravastatin—coronary artery disease	3.05e-05	0.000119	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Ramipril—coronary artery disease	3.04e-05	0.000119	CcSEcCtD
Lenalidomide—Paraesthesia—Lisinopril—coronary artery disease	3.03e-05	0.000119	CcSEcCtD
Lenalidomide—Vomiting—Captopril—coronary artery disease	3.03e-05	0.000119	CcSEcCtD
Lenalidomide—Dyspnoea—Lisinopril—coronary artery disease	3.01e-05	0.000118	CcSEcCtD
Lenalidomide—Rash—Captopril—coronary artery disease	3.01e-05	0.000118	CcSEcCtD
Lenalidomide—Dermatitis—Captopril—coronary artery disease	3e-05	0.000117	CcSEcCtD
Lenalidomide—Somnolence—Lisinopril—coronary artery disease	3e-05	0.000117	CcSEcCtD
Lenalidomide—Feeling abnormal—Timolol—coronary artery disease	3e-05	0.000117	CcSEcCtD
Lenalidomide—Headache—Captopril—coronary artery disease	2.99e-05	0.000117	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Timolol—coronary artery disease	2.98e-05	0.000116	CcSEcCtD
Lenalidomide—Dizziness—Furosemide—coronary artery disease	2.98e-05	0.000116	CcSEcCtD
Lenalidomide—Dyspepsia—Lisinopril—coronary artery disease	2.97e-05	0.000116	CcSEcCtD
Lenalidomide—Diarrhoea—Losartan—coronary artery disease	2.97e-05	0.000116	CcSEcCtD
Lenalidomide—Nausea—Trandolapril—coronary artery disease	2.96e-05	0.000116	CcSEcCtD
Lenalidomide—Urticaria—Ramipril—coronary artery disease	2.96e-05	0.000116	CcSEcCtD
Lenalidomide—Nausea—Enalapril—coronary artery disease	2.95e-05	0.000115	CcSEcCtD
Lenalidomide—Vomiting—Perindopril—coronary artery disease	2.94e-05	0.000115	CcSEcCtD
Lenalidomide—Abdominal pain—Ramipril—coronary artery disease	2.94e-05	0.000115	CcSEcCtD
Lenalidomide—Body temperature increased—Ramipril—coronary artery disease	2.94e-05	0.000115	CcSEcCtD
Lenalidomide—Decreased appetite—Lisinopril—coronary artery disease	2.94e-05	0.000115	CcSEcCtD
Lenalidomide—Rash—Perindopril—coronary artery disease	2.92e-05	0.000114	CcSEcCtD
Lenalidomide—Dermatitis—Perindopril—coronary artery disease	2.92e-05	0.000114	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Lisinopril—coronary artery disease	2.91e-05	0.000114	CcSEcCtD
Lenalidomide—Nausea—Telmisartan—coronary artery disease	2.91e-05	0.000114	CcSEcCtD
Lenalidomide—Fatigue—Lisinopril—coronary artery disease	2.91e-05	0.000114	CcSEcCtD
Lenalidomide—Headache—Perindopril—coronary artery disease	2.9e-05	0.000113	CcSEcCtD
Lenalidomide—Urticaria—Timolol—coronary artery disease	2.89e-05	0.000113	CcSEcCtD
Lenalidomide—Pain—Lisinopril—coronary artery disease	2.89e-05	0.000113	CcSEcCtD
Lenalidomide—Constipation—Lisinopril—coronary artery disease	2.89e-05	0.000113	CcSEcCtD
Lenalidomide—Abdominal pain—Timolol—coronary artery disease	2.88e-05	0.000113	CcSEcCtD
Lenalidomide—Body temperature increased—Timolol—coronary artery disease	2.88e-05	0.000113	CcSEcCtD
Lenalidomide—Dizziness—Losartan—coronary artery disease	2.87e-05	0.000112	CcSEcCtD
Lenalidomide—Vomiting—Furosemide—coronary artery disease	2.86e-05	0.000112	CcSEcCtD
Lenalidomide—Rash—Furosemide—coronary artery disease	2.84e-05	0.000111	CcSEcCtD
Lenalidomide—Dermatitis—Furosemide—coronary artery disease	2.83e-05	0.000111	CcSEcCtD
Lenalidomide—Nausea—Captopril—coronary artery disease	2.83e-05	0.000111	CcSEcCtD
Lenalidomide—Headache—Furosemide—coronary artery disease	2.82e-05	0.00011	CcSEcCtD
Lenalidomide—Feeling abnormal—Lisinopril—coronary artery disease	2.78e-05	0.000109	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Lisinopril—coronary artery disease	2.76e-05	0.000108	CcSEcCtD
Lenalidomide—Vomiting—Losartan—coronary artery disease	2.76e-05	0.000108	CcSEcCtD
Lenalidomide—Nausea—Perindopril—coronary artery disease	2.75e-05	0.000108	CcSEcCtD
Lenalidomide—Hypersensitivity—Ramipril—coronary artery disease	2.74e-05	0.000107	CcSEcCtD
Lenalidomide—Rash—Losartan—coronary artery disease	2.74e-05	0.000107	CcSEcCtD
Lenalidomide—Dermatitis—Losartan—coronary artery disease	2.74e-05	0.000107	CcSEcCtD
Lenalidomide—Headache—Losartan—coronary artery disease	2.72e-05	0.000106	CcSEcCtD
Lenalidomide—Urticaria—Lisinopril—coronary artery disease	2.68e-05	0.000105	CcSEcCtD
Lenalidomide—Hypersensitivity—Timolol—coronary artery disease	2.68e-05	0.000105	CcSEcCtD
Lenalidomide—Nausea—Furosemide—coronary artery disease	2.67e-05	0.000105	CcSEcCtD
Lenalidomide—Asthenia—Ramipril—coronary artery disease	2.67e-05	0.000104	CcSEcCtD
Lenalidomide—Abdominal pain—Lisinopril—coronary artery disease	2.67e-05	0.000104	CcSEcCtD
Lenalidomide—Body temperature increased—Lisinopril—coronary artery disease	2.67e-05	0.000104	CcSEcCtD
Lenalidomide—Pruritus—Ramipril—coronary artery disease	2.63e-05	0.000103	CcSEcCtD
Lenalidomide—Asthenia—Timolol—coronary artery disease	2.61e-05	0.000102	CcSEcCtD
Lenalidomide—Nausea—Losartan—coronary artery disease	2.58e-05	0.000101	CcSEcCtD
Lenalidomide—Pruritus—Timolol—coronary artery disease	2.57e-05	0.000101	CcSEcCtD
Lenalidomide—Diarrhoea—Ramipril—coronary artery disease	2.55e-05	9.96e-05	CcSEcCtD
Lenalidomide—Diarrhoea—Timolol—coronary artery disease	2.49e-05	9.74e-05	CcSEcCtD
Lenalidomide—Hypersensitivity—Lisinopril—coronary artery disease	2.49e-05	9.73e-05	CcSEcCtD
Lenalidomide—Dizziness—Ramipril—coronary artery disease	2.46e-05	9.63e-05	CcSEcCtD
Lenalidomide—Asthenia—Lisinopril—coronary artery disease	2.42e-05	9.47e-05	CcSEcCtD
Lenalidomide—Dizziness—Timolol—coronary artery disease	2.41e-05	9.41e-05	CcSEcCtD
Lenalidomide—Pruritus—Lisinopril—coronary artery disease	2.39e-05	9.34e-05	CcSEcCtD
Lenalidomide—Vomiting—Ramipril—coronary artery disease	2.37e-05	9.26e-05	CcSEcCtD
Lenalidomide—Rash—Ramipril—coronary artery disease	2.35e-05	9.18e-05	CcSEcCtD
Lenalidomide—Dermatitis—Ramipril—coronary artery disease	2.35e-05	9.17e-05	CcSEcCtD
Lenalidomide—Headache—Ramipril—coronary artery disease	2.33e-05	9.12e-05	CcSEcCtD
Lenalidomide—Vomiting—Timolol—coronary artery disease	2.31e-05	9.05e-05	CcSEcCtD
Lenalidomide—Diarrhoea—Lisinopril—coronary artery disease	2.31e-05	9.03e-05	CcSEcCtD
Lenalidomide—Rash—Timolol—coronary artery disease	2.29e-05	8.97e-05	CcSEcCtD
Lenalidomide—Dermatitis—Timolol—coronary artery disease	2.29e-05	8.97e-05	CcSEcCtD
Lenalidomide—Headache—Timolol—coronary artery disease	2.28e-05	8.92e-05	CcSEcCtD
Lenalidomide—Dizziness—Lisinopril—coronary artery disease	2.23e-05	8.73e-05	CcSEcCtD
Lenalidomide—Nausea—Ramipril—coronary artery disease	2.21e-05	8.65e-05	CcSEcCtD
Lenalidomide—Nausea—Timolol—coronary artery disease	2.16e-05	8.45e-05	CcSEcCtD
Lenalidomide—Vomiting—Lisinopril—coronary artery disease	2.15e-05	8.39e-05	CcSEcCtD
Lenalidomide—Rash—Lisinopril—coronary artery disease	2.13e-05	8.32e-05	CcSEcCtD
Lenalidomide—Dermatitis—Lisinopril—coronary artery disease	2.13e-05	8.32e-05	CcSEcCtD
Lenalidomide—Headache—Lisinopril—coronary artery disease	2.12e-05	8.27e-05	CcSEcCtD
Lenalidomide—Nausea—Lisinopril—coronary artery disease	2.01e-05	7.84e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—CPT1B—coronary artery disease	1.53e-05	0.000135	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HK1—coronary artery disease	1.53e-05	0.000135	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AK1—coronary artery disease	1.53e-05	0.000134	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCH1—coronary artery disease	1.53e-05	0.000134	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MAPK1—coronary artery disease	1.51e-05	0.000133	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA4—coronary artery disease	1.51e-05	0.000133	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	1.49e-05	0.000131	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL6—coronary artery disease	1.48e-05	0.000131	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.48e-05	0.00013	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLCD1—coronary artery disease	1.46e-05	0.000129	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MDH2—coronary artery disease	1.46e-05	0.000129	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—UGCG—coronary artery disease	1.46e-05	0.000129	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPAT—coronary artery disease	1.46e-05	0.000129	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	1.46e-05	0.000128	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—coronary artery disease	1.45e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PDHA1—coronary artery disease	1.45e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GCLM—coronary artery disease	1.45e-05	0.000128	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	1.45e-05	0.000128	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NR4A1—coronary artery disease	1.44e-05	0.000127	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—CETP—coronary artery disease	1.43e-05	0.000126	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HDAC9—coronary artery disease	1.43e-05	0.000126	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.41e-05	0.000124	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TXNRD1—coronary artery disease	1.41e-05	0.000124	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP11B2—coronary artery disease	1.41e-05	0.000124	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PGM1—coronary artery disease	1.41e-05	0.000124	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—P4HB—coronary artery disease	1.39e-05	0.000122	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC22A3—coronary artery disease	1.39e-05	0.000122	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—coronary artery disease	1.38e-05	0.000122	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ARNTL—coronary artery disease	1.37e-05	0.00012	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HADH—coronary artery disease	1.37e-05	0.00012	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PPP3R1—coronary artery disease	1.36e-05	0.00012	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PYGB—coronary artery disease	1.36e-05	0.00012	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CKB—coronary artery disease	1.36e-05	0.00012	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—TFRC—coronary artery disease	1.36e-05	0.00012	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.35e-05	0.000119	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	1.34e-05	0.000118	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NPPA—coronary artery disease	1.32e-05	0.000116	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CYBB—coronary artery disease	1.32e-05	0.000116	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.31e-05	0.000116	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PIK3CA—coronary artery disease	1.31e-05	0.000116	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	1.31e-05	0.000116	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—coronary artery disease	1.31e-05	0.000116	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GPX2—coronary artery disease	1.3e-05	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLA2G2A—coronary artery disease	1.3e-05	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA2—coronary artery disease	1.3e-05	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MAP2K3—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—VCAN—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HK1—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GPX4—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCG5—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SULT1A1—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DLAT—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTM2—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLIN1—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PFKFB3—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—COX5B—coronary artery disease	1.28e-05	0.000113	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ALDOA—coronary artery disease	1.27e-05	0.000112	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HADHA—coronary artery disease	1.26e-05	0.000111	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—PLAT—coronary artery disease	1.26e-05	0.000111	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTA1—coronary artery disease	1.25e-05	0.00011	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	1.25e-05	0.00011	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CST3—coronary artery disease	1.25e-05	0.00011	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—DCN—coronary artery disease	1.24e-05	0.000109	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LPA—coronary artery disease	1.24e-05	0.000109	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—coronary artery disease	1.22e-05	0.000107	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SULT1E1—coronary artery disease	1.21e-05	0.000107	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLCB3—coronary artery disease	1.2e-05	0.000105	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	1.19e-05	0.000104	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA5—coronary artery disease	1.18e-05	0.000104	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOC3—coronary artery disease	1.17e-05	0.000103	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6—coronary artery disease	1.16e-05	0.000102	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—P4HB—coronary artery disease	1.16e-05	0.000102	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—LDLR—coronary artery disease	1.16e-05	0.000102	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HK2—coronary artery disease	1.16e-05	0.000102	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AKR1B1—coronary artery disease	1.16e-05	0.000102	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.15e-05	0.000101	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC9A1—coronary artery disease	1.14e-05	0.000101	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLA2G1B—coronary artery disease	1.14e-05	0.0001	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	1.14e-05	0.0001	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.13e-05	9.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SDC1—coronary artery disease	1.12e-05	9.85e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.11e-05	9.82e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC27A1—coronary artery disease	1.11e-05	9.77e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CPT1B—coronary artery disease	1.09e-05	9.58e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LCAT—coronary artery disease	1.09e-05	9.58e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—VCAN—coronary artery disease	1.08e-05	9.47e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—PLG—coronary artery disease	1.07e-05	9.47e-05	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AKT1—coronary artery disease	1.07e-05	9.45e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALDOA—coronary artery disease	1.07e-05	9.4e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA4—coronary artery disease	1.07e-05	9.4e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PSMA6—coronary artery disease	1.06e-05	9.31e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PSMB5—coronary artery disease	1.06e-05	9.31e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DCN—coronary artery disease	1.04e-05	9.13e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	1.03e-05	9.1e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PDHA1—coronary artery disease	1.03e-05	9.08e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCLM—coronary artery disease	1.03e-05	9.08e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GOT2—coronary artery disease	1.02e-05	9.01e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CYBA—coronary artery disease	1.02e-05	8.97e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CALR—coronary artery disease	1.01e-05	8.93e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALDH2—coronary artery disease	1.01e-05	8.88e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TXNRD1—coronary artery disease	9.98e-06	8.79e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP11B2—coronary artery disease	9.98e-06	8.79e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	9.92e-06	8.74e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC22A3—coronary artery disease	9.83e-06	8.66e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	9.82e-06	8.65e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LIPC—coronary artery disease	9.82e-06	8.65e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP2C19—coronary artery disease	9.82e-06	8.65e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HBA1—coronary artery disease	9.82e-06	8.65e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3C2A—coronary artery disease	9.82e-06	8.65e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOC3—coronary artery disease	9.76e-06	8.6e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LDLR—coronary artery disease	9.7e-06	8.54e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	9.69e-06	8.54e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ARNTL—coronary artery disease	9.69e-06	8.54e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HADH—coronary artery disease	9.69e-06	8.54e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC9A1—coronary artery disease	9.58e-06	8.44e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTT1—coronary artery disease	9.58e-06	8.44e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOB—coronary artery disease	9.5e-06	8.37e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	9.48e-06	8.36e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GCLC—coronary artery disease	9.47e-06	8.35e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CETP—coronary artery disease	9.47e-06	8.35e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—JUNB—coronary artery disease	9.44e-06	8.32e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HSPA1A—coronary artery disease	9.44e-06	8.32e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SDC1—coronary artery disease	9.37e-06	8.25e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	9.3e-06	8.19e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	9.3e-06	8.19e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA2—coronary artery disease	9.18e-06	8.09e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLA2G2A—coronary artery disease	9.18e-06	8.09e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GPX2—coronary artery disease	9.18e-06	8.09e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ABCG5—coronary artery disease	9.07e-06	7.99e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SULT1A1—coronary artery disease	9.07e-06	7.99e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GPX4—coronary artery disease	9.07e-06	7.99e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HK1—coronary artery disease	9.07e-06	7.99e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HADHA—coronary artery disease	8.96e-06	7.9e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTA1—coronary artery disease	8.86e-06	7.81e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	8.86e-06	7.8e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PSMB5—coronary artery disease	8.85e-06	7.8e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PSMA6—coronary artery disease	8.85e-06	7.8e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	8.83e-06	7.78e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GOT1—coronary artery disease	8.83e-06	7.78e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LPA—coronary artery disease	8.76e-06	7.72e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CTGF—coronary artery disease	8.64e-06	7.62e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HMGCR—coronary artery disease	8.57e-06	7.55e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GOT2—coronary artery disease	8.57e-06	7.55e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLCB3—coronary artery disease	8.49e-06	7.48e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA5—coronary artery disease	8.4e-06	7.4e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—P4HB—coronary artery disease	8.24e-06	7.26e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PRKCE—coronary artery disease	8.15e-06	7.18e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLA2G1B—coronary artery disease	8.09e-06	7.12e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	8.07e-06	7.11e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFBR2—coronary artery disease	7.93e-06	6.99e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—KITLG—coronary artery disease	7.93e-06	6.99e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLCB1—coronary artery disease	7.88e-06	6.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—STAT5A—coronary artery disease	7.75e-06	6.83e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCA1—coronary artery disease	7.64e-06	6.73e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—VCAN—coronary artery disease	7.62e-06	6.72e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALDOA—coronary artery disease	7.56e-06	6.66e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—coronary artery disease	7.51e-06	6.62e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOB—coronary artery disease	7.49e-06	6.6e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GOT1—coronary artery disease	7.4e-06	6.52e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GGT1—coronary artery disease	7.4e-06	6.52e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DCN—coronary artery disease	7.34e-06	6.47e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FGF1—coronary artery disease	7.21e-06	6.35e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—LPL—coronary artery disease	7.15e-06	6.3e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALDH2—coronary artery disease	7.14e-06	6.29e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP2C19—coronary artery disease	6.96e-06	6.13e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LIPC—coronary artery disease	6.96e-06	6.13e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3C2A—coronary artery disease	6.96e-06	6.13e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HBA1—coronary artery disease	6.96e-06	6.13e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOC3—coronary artery disease	6.92e-06	6.09e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LDLR—coronary artery disease	6.88e-06	6.06e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC9A1—coronary artery disease	6.79e-06	5.99e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTT1—coronary artery disease	6.79e-06	5.99e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CETP—coronary artery disease	6.72e-06	5.92e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GCLC—coronary artery disease	6.72e-06	5.92e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PPP2CA—coronary artery disease	6.71e-06	5.91e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTP1—coronary artery disease	6.64e-06	5.85e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SDC1—coronary artery disease	6.64e-06	5.85e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	6.59e-06	5.81e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PRKCD—coronary artery disease	6.59e-06	5.81e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARGC1A—coronary artery disease	6.58e-06	5.8e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HMOX1—coronary artery disease	6.55e-06	5.77e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CAT—coronary artery disease	6.46e-06	5.69e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTHFR—coronary artery disease	6.44e-06	5.68e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOB—coronary artery disease	6.28e-06	5.53e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PSMA6—coronary artery disease	6.27e-06	5.53e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PSMB5—coronary artery disease	6.27e-06	5.53e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HIF1A—coronary artery disease	6.14e-06	5.41e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CTGF—coronary artery disease	6.13e-06	5.4e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTM1—coronary artery disease	6.1e-06	5.38e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GOT2—coronary artery disease	6.07e-06	5.35e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMGCR—coronary artery disease	6.07e-06	5.35e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOE—coronary artery disease	6e-06	5.28e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LPL—coronary artery disease	5.99e-06	5.28e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	5.95e-06	5.25e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOA1—coronary artery disease	5.93e-06	5.22e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GPX1—coronary artery disease	5.85e-06	5.15e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CD36—coronary artery disease	5.69e-06	5.02e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6ST—coronary artery disease	5.63e-06	4.96e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPP2CA—coronary artery disease	5.62e-06	4.95e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS2—coronary artery disease	5.59e-06	4.92e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLCB1—coronary artery disease	5.58e-06	4.92e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ABCA1—coronary artery disease	5.41e-06	4.77e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—KIT—coronary artery disease	5.41e-06	4.77e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MTHFR—coronary artery disease	5.4e-06	4.75e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GGT1—coronary artery disease	5.24e-06	4.62e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GOT1—coronary artery disease	5.24e-06	4.62e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GSK3B—coronary artery disease	5.19e-06	4.58e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CREB1—coronary artery disease	5.15e-06	4.54e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AGT—coronary artery disease	5.13e-06	4.52e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6R—coronary artery disease	5.03e-06	4.43e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOE—coronary artery disease	5.02e-06	4.42e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA1—coronary artery disease	4.97e-06	4.37e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.75e-06	4.19e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTP1—coronary artery disease	4.71e-06	4.15e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SERPINE1—coronary artery disease	4.71e-06	4.15e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARGC1A—coronary artery disease	4.67e-06	4.11e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMOX1—coronary artery disease	4.64e-06	4.09e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CAT—coronary artery disease	4.58e-06	4.04e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FGF2—coronary artery disease	4.56e-06	4.01e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS3—coronary artery disease	4.49e-06	3.96e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOB—coronary artery disease	4.45e-06	3.92e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARG—coronary artery disease	4.37e-06	3.85e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—JAK2—coronary artery disease	4.37e-06	3.85e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTM1—coronary artery disease	4.33e-06	3.81e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—POMC—coronary artery disease	4.31e-06	3.8e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LPL—coronary artery disease	4.25e-06	3.74e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GPX1—coronary artery disease	4.14e-06	3.65e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CD36—coronary artery disease	4.04e-06	3.56e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPP2CA—coronary artery disease	3.99e-06	3.51e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—coronary artery disease	3.93e-06	3.47e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MTHFR—coronary artery disease	3.82e-06	3.37e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NOS3—coronary artery disease	3.76e-06	3.32e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AGT—coronary artery disease	3.63e-06	3.2e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOE—coronary artery disease	3.56e-06	3.14e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA1—coronary artery disease	3.52e-06	3.1e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARG—coronary artery disease	3.1e-06	2.73e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—POMC—coronary artery disease	3.06e-06	2.69e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFB1—coronary artery disease	2.97e-06	2.62e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MAPK1—coronary artery disease	2.91e-06	2.57e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—coronary artery disease	2.79e-06	2.46e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NOS3—coronary artery disease	2.67e-06	2.35e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PIK3CA—coronary artery disease	2.53e-06	2.23e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—coronary artery disease	2.44e-06	2.15e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—coronary artery disease	2.24e-06	1.97e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3CA—coronary artery disease	2.12e-06	1.87e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKT1—coronary artery disease	2.07e-06	1.82e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AKT1—coronary artery disease	1.73e-06	1.52e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3CA—coronary artery disease	1.5e-06	1.32e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AKT1—coronary artery disease	1.23e-06	1.08e-05	CbGpPWpGaD
